Gender related association between genetic variations of APOC-III gene and lipid and lipoprotein variables in northern France.

[1]  H. Tunstall-Pedoe,et al.  Myocardial Infarction and Coronary Deaths in the World Health Organization MONICA Project: Registration Procedures, Event Rates, and Case‐Fatality Rates in 38 Populations From 21 Countries in Four Continents , 1994, Circulation.

[2]  J. Rotter,et al.  Apolipoprotein A-I/C-III/A-IV gene cluster in familial combined hyperlipidemia: effects on LDL-cholesterol and apolipoproteins B and C-III. , 1996, Journal of lipid research.

[3]  J. Viikari,et al.  DNA polymorphisms of the apolipoprotein B and A-I/C-III genes are associated with variations of serum low density lipoprotein cholesterol level in childhood. , 1991, Journal of lipid research.

[4]  Hoffer,et al.  Increased risk for endogenous hypertriglyceridaemia is associated with an apolipoprotein C3 haplotype specified by the SstI polymorphism , 1998, European journal of clinical investigation.

[5]  R. Mahley,et al.  Plasma lipoproteins: apolipoprotein structure and function. , 1984, Journal of lipid research.

[6]  A. Kessling,et al.  Patterns of association between genetic variability in apolipoprotein (apo) B, apo AI-CIII-AIV, and cholesterol ester transfer protein gene regions and quantitative variation in lipid and lipoprotein traits: influence of gender and exogenous hormones. , 1992, American journal of human genetics.

[7]  D. C. Rao,et al.  Estimation of myriad haplotype frequencies , 1985, Genetic epidemiology.

[8]  T. Lehtimäki,et al.  Variability gene effects of DNA polymorphisms at the apo B, apo AI/C III and apo E loci on serum lipids: the Cardiovascular Risk in Young Finns Study , 1994, Clinical genetics.

[9]  Chun-Fang Xu,et al.  Association between genetic variation at the APO AI‐CIII‐AIV gene cluster and familial combined hyperlipidaemia , 1994, Clinical genetics.

[10]  K. Mullis,et al.  Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. , 1985, Science.

[11]  D. Galton,et al.  Haplotypes identified by DNA restriction-fragment-length polymorphisms in the A-1 C-III A-IV gene region and hypertriglyceridemia. , 1987, American journal of human genetics.

[12]  S. Grundy,et al.  Variation at the hepatic lipase and apolipoprotein AI/CIII/AIV loci is a major cause of genetically determined variation in plasma HDL cholesterol levels. , 1994, The Journal of clinical investigation.

[13]  E. Wijsman,et al.  Evidence against linkage of familial combined hyperlipidemia to the apolipoprotein AI-CIII-AIV gene complex. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[14]  V. Gudnason,et al.  Variation at the lipoprotein lipase and apolipoprotein AI‐CIII gene loci are associated with fasting lipid and lipoprotein traits in a population sample from Iceland: Interaction between genotype, gender, and smoking status , 1997, Genetic epidemiology.

[15]  Jin Q. Kim,et al.  Association between genetic variations of apo AI-CIII-AIV cluster gene and hypertriglyceridemic subjects. , 1997, Clinical chemistry.

[16]  Chun-Fang Xu,et al.  Role of genetic variation at the Apo AI‐CIII‐AIV gene cluster in determining plasma Apo AI levels in boys and girls , 1993, Genetic epidemiology.

[17]  C. Sing,et al.  Cladistic analysis of the apolipoprotein AI‐CIH‐AIV gene cluster using a healthy French Canadian sample. I. Haploid analysis , 1995, Annals of human genetics.

[18]  D. Arveiler,et al.  Lack of association between genetic variations of apo A-I-C-III-A-IV gene cluster and myocardial infarction in a sample of European male: ECTIM study. , 1999, Atherosclerosis.

[19]  S. Humphries,et al.  A variation in the apolipoprotein C-III gene is associated with an increased number of circulating VLDL and IDL particles in familial combined hyperlipidemia. , 1997, Journal of lipid research.

[20]  Y. Ko,et al.  Interaction between obesity and genetic polymorphisms in the apolipoprotein CIII gene and lipoprotein lipase gene on the risk of hypertriglyceridemia in Chinese , 1997, Human Genetics.

[21]  T. Burns,et al.  Restriction fragment length polymorphisms associated with abnormal lipid levels in an adolescent population. , 1989, Atherosclerosis.

[22]  P. Talmud,et al.  Variation at the apolipoprotein (apo) AI-CIII-AIV gene cluster and apo B gene loci is associated with lipoprotein and apolipoprotein levels in Italian children. , 1990, American journal of human genetics.

[23]  N. Cox,et al.  Linkage disequilibrium in the human insulin/insulin-like growth factor II region of human chromosome II. , 1988, American journal of human genetics.

[24]  N. Cox,et al.  Hypertriglyceridemia and the apolipoprotein CIII gene locus: lack of association with the variant insulin response element in Italian school children , 1996, Human Genetics.

[25]  E. Boerwinkle,et al.  Polymorphic markers in apolipoprotein C-III gene flanking regions and hypertriglyceridemia. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[26]  J. Rotter,et al.  Complex genetic contribution of the Apo AI-CIII-AIV gene cluster to familial combined hyperlipidemia. Identification of different susceptibility haplotypes. , 1997, The Journal of clinical investigation.

[27]  P. Talmud,et al.  Apolipoprotein C-III gene variation and dyslipidaemia. , 1997, Current opinion in lipidology.

[28]  L. Peltonen,et al.  Haplotypes of the ApoA-I/C-III/A-IV gene cluster and familial combined hyperlipidemia. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[29]  B. Zinman,et al.  Common genomic variants associated with variation in plasma lipoproteins in young aboriginal Canadians. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[30]  Shirley A. Miller,et al.  A simple salting out procedure for extracting DNA from human nucleated cells. , 1988, Nucleic acids research.

[31]  B. Zinman,et al.  Common genomic variation in the APOC3 promoter associated with variation in plasma lipoproteins. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[32]  M. Hayden,et al.  Lack of association of the apolipoprotein A-I-C-III-A-IV gene XmnI and SstI polymorphisms and of the lipoprotein lipase gene mutations in familial combined hyperlipoproteinemia in French Canadian subjects. , 1996, Journal of lipid research.

[33]  J. Breslow,et al.  An apolipoprotein CIII haplotype protective against hypertriglyceridemia is specified by promoter and 3' untranslated region polymorphisms. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[34]  C. Shoulders,et al.  Deoxyribonucleic acid polymorphism in the apolipoprotein A-1-C-III gene cluster. Association with hypertriglyceridemia. , 1985, The Journal of clinical investigation.

[35]  D. Arveiler,et al.  The role of a triplet repeat sequence of the very low density lipoprotein receptor gene in plasma lipid and lipoprotein level variability in humans. , 1997, Arteriosclerosis, thrombosis, and vascular biology.